Bill S-225 explained in plain English

On April 13, 2016, Bill S-225, an Act to amend the Controlled Drugs and Substances Act concerning substances used in the production of fentanyl, was introduced in the Senate for its first reading. The Senate then proceeded with other routine proceedings, orders of the day, and question period, which included discussions on various topics such as the Energy East Pipeline, a University hockey championship, acts of terrorism in Pakistan, the closure of a fish processing plant, and tributes to individuals. The Minister of Transport also answered questions regarding railway safety, drone regulations, laser technology, Air Canada maintenance, airport security, unaccompanied minors, transport efficiency, maritime infrastructure, and grain transportation. The Senate adjourned later that day.

The Senate convened for a sitting on April 21, 2016. A significant portion of the debate focused on Bill S-225, an Act to amend the Controlled Drugs and Substances Act, which aims to regulate substances used in the production of fentanyl by classifying them as Class A precursors. Senator Vernon White introduced the bill, highlighting the severe opioid crisis in Canada, particularly related to fentanyl, and explaining how regulating precursors would provide law enforcement and health authorities with another tool to combat illegal fentanyl production and trafficking. The debate included questions about the effectiveness of such measures and potential unintended consequences, as well as discussions on international cooperation, especially with China, to control the flow of these substances. Other proceedings included congratulatory remarks for Queen Elizabeth II's 90th birthday, recognition of Robert Pichette for the French Legion of Honour, a discussion on protecting underground infrastructure, and several notices of motions and inquiries on various topics including budget implementation, national security, human rights in Iran, and petitions regarding French language services and caregiver benefits. The Senate also addressed procedural matters such as adjusting the start time for a future sitting and continuing debate on other bills.

This artifact details a Senate debate on April 21, 2016, concerning Bill S-225. The bill aims to amend the Controlled Drugs and Substances Act by classifying certain substances used in the production of fentanyl as Class A precursors. Senator Vernon White, the sponsor of the bill, presented the second reading speech. He highlighted the escalating crisis of fentanyl-related deaths and overdoses in Canada, explaining that the bill intends to provide law enforcement and health officials with an additional tool to combat the illegal production and distribution of fentanyl by controlling its precursor ingredients. Other senators raised questions about the bill's effectiveness, potential unintended consequences, and enforcement mechanisms, particularly regarding the detection and interception of precursor substances. Discussions also touched upon international cooperation, especially with China, and the need for updated precursor lists in line with international partners like the United States and Australia. The debate was adjourned for further discussion.

This artifact is a record of a Senate sitting on May 12, 2016. During this sitting, the Senate proceeded with various items of business, including statements by senators on topics such as the Energy East Pipeline and an Aboriginal Engagement Strategy, the presentation of committee reports on studies related to French-language schools in British Columbia and Syrian refugees, the first reading of a private bill, and a notice of motion regarding tensions in the South China Sea. The sitting also included a question period where senators asked the Government Representative in the Senate about electoral reform, the auxiliary constable program, workers' safety, recreational marijuana, and the situation in Ethiopia. The Senate adopted a motion to adjust the schedule for Question Period on a future date and authorized a committee to study supplementary estimates. The sitting also featured continued debate on a bill to amend the Criminal Code concerning sentencing for violent offences against Aboriginal women and the second reading of Bill S-225, an Act to amend the Controlled Drugs and Substances Act (substances used in the production of fentanyl), which was subsequently referred to committee. Debate on an inquiry concerning human rights abuses in Iran and a motion to amend the Rules of the Senate regarding legislative reports were adjourned.

This record details a debate in the Senate concerning Bill S-225, an Act to amend the Controlled Drugs and Substances Act. The debate primarily focused on substances used in the production of fentanyl. Senator Wilfred P. Moore spoke as the critic for the bill, detailing the dangers of fentanyl, its potency, and the rising number of overdose deaths in Canada. He highlighted that illegal fentanyl enters Canada either through the misuse of prescribed fentanyl patches or by smuggling fentanyl or its precursor chemicals from abroad. The bill aims to make these precursor chemicals illegal to prevent the domestic manufacturing of fentanyl. Senator Moore also discussed the broader issue of opioid addiction stemming from over-prescription in the healthcare system and noted that Canada's prescribing guidelines have not been updated since 2010, lagging behind some provincial efforts and U.S. guidelines. Senator Jane Cordy questioned the effectiveness of current measures and the role of the federal government in regulating prescription opioids, drawing parallels with the United States' actions regarding OxyContin. Following the debate, Bill S-225 was referred to the Standing Senate Committee on Legal and Constitutional Affairs.

On June 10, 2016, the Senate of Canada convened. A significant procedural item was the presentation of the sixth report from the Standing Senate Committee on Legal and Constitutional Affairs regarding Bill S-225, An Act to amend the Controlled Drugs and Substances Act (substances used in the production of fentanyl). This report included proposed amendments to the bill. The Senate also held debates and proceedings on other matters, including tributes to former Senators Len Marchand and Rod Zimmer, and debated Bill C-14 concerning medical assistance in dying. The report on Bill S-225 was placed on the Orders of the Day for consideration at a future sitting. No vote or final decision on Bill S-225 was recorded in this artifact.

This record details a Senate sitting where various procedural matters were addressed, including tabling reports, presenting committee findings, and engaging in debates. A key procedural event was the consideration and adoption of the sixth report from the Standing Senate Committee on Legal and Constitutional Affairs concerning Bill S-225, An Act to amend the Controlled Drugs and Substances Act (substances used in the production of fentanyl). Following the adoption of the report, Bill S-225 proceeded to third reading and was passed by the Senate. The sitting also included Question Period, where senators asked questions on various government matters, and debates on other legislative items, including Bill C-15, the Budget Implementation Act, 2016.

This record documents the Senate's third reading of Bill S-225, an Act to amend the Controlled Drugs and Substances Act concerning substances used in the production of fentanyl. During this stage, the bill was discussed, amended, and ultimately passed. The debate focused on the urgent need to regulate fentanyl precursors to combat the drug's devastating impact, including addiction and death. Senators highlighted the challenges of illicit fentanyl production and importation, the risks to first responders, and the slow pace of regulatory action compared to other countries. The bill's passage was seen as a critical step in providing law enforcement with tools to disrupt the supply of illegal fentanyl. The record also includes other Senate business such as tabling reports, committee presentations, and debates on other bills, but the focus here is on Bill S-225.